Signals we assess
Clinical indicators we measure at intake
Klarity’s intake consult benchmarks treatment-resistant depression biomarkers, mood-tracking patterns, cognitive performance, and nervous system resilience. The result is a precision roadmap that prioritizes regulation before any infusion or neuromodulation begins.
- Persistent low mood or anhedonia despite multiple medication trials
- High-functioning professionals masking severe internal depression
- Patients transitioning out of inpatient or PHP/IOP programs
Personalized protocols
How our team delivers regenerative treatment-resistant depression treatment
Your integrated care team pairs our ketamine-enhanced therapy with stellate ganglion blocks (if appropriate, currently available in Upland only), neuromodulation, nutrient optimization, and hospitality-level recovery spaces. The plan flexes around real-time data so the protocol stays aligned with your goals.
- Rapid-acting IV ketamine series calibrated with mood telemetry
- Medication reconciliation with psychotherapy and mind-body integration
- Lifestyle redesign and concierge follow-up for sustainable change
Integration & outcomes
Sustained gains beyond the infusion chair
Klarity tracks every phase of your treatment-resistant depression progress with validated assessments, biometric feedback, and a curated integration playbook. Expect concierge check-ins, habit scaffolding, and cross-talk with your existing providers to keep breakthroughs anchored.